Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Kozhnosys Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1)Willing to sign the informed consent form. 2)Females aged 18 years and above. 3)Confirmed cases of breast cancer -positive mammography/breast sonography/breast examination report (but not exposed to any treatment cycle/surgery for tumor removal); and willing to undergo further MRI /biopsy if required. 4)Women with negative mammography/breast sonography reports and willing to undergo further MRI if required.
Exclusion criteria
Exclusion criteria: 1)Patients undergoing breast cancer treatment. 2)Patients who have undergone surgery for breast tumor removal. 3)Patients with negative mammography/breast sonography reports. 4)Patients without breast examination report from PI. 5)Pregnant & lactating mothers. 6)Previous history of treated breast cancer, or cancer of any other site, except basal cell carcinoma of the skin. 7)Consumption of alcohol, pan, gutkha within less than 12 hrs. 8)Smoking within the last one month 9)Breast cancer patients who do not share a biopsy report.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity: The study will estimate sensitivity and specificity rates for the CanScan Breath Analyzer in screening all stage breast cancer. This would measure the tool s effectiveness in correctly distinguishing between breast cancer patients and healthy subject.Timepoint: 32 | — |
Secondary
| Measure | Time frame |
|---|---|
| Breath Test acceptance & subject satisfaction: Highlight the non-invasive nature of the screening method, measuring subject s ease of use compared to traditional screening methods like mammograms.Timepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactJilma Peruvangat
Kozhnosys Pvt. Ltd.
Outcome results
None listed